Capital Management Corp Exelixis, Inc. Transaction History
Capital Management Corp
- $480 Million
- Q4 2024
A detailed history of Capital Management Corp transactions in Exelixis, Inc. stock. As of the latest transaction made, Capital Management Corp holds 334,045 shares of EXEL stock, worth $12.8 Million. This represents 2.32% of its overall portfolio holdings.
Number of Shares
334,045
Previous 365,270
8.55%
Holding current value
$12.8 Million
Previous $9.48 Million
17.36%
% of portfolio
2.32%
Previous 1.94%
Shares
26 transactions
Others Institutions Holding EXEL
# of Institutions
566Shares Held
251MCall Options Held
1.45MPut Options Held
1.13M-
Black Rock Inc. New York, NY33.5MShares$1.28 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.4MShares$1.13 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA23.4MShares$897 Million4.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.3MShares$586 Million0.8% of portfolio
-
State Street Corp Boston, MA11.4MShares$437 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $12.3B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...